Convidado

AMIT SINGAL

Professor in the Department of Internal Medicine at UT Southwestern Medical Center, and a member of its Division of Digestive & Liver Diseases. He is an expert in hepatocellular carcinoma and serves as the Medical Director of the UT Southwestern Liver Tumor Program. He also is a Dedman Family Scholar in Clinical Care and holds the Willis C. Maddrey, M.D. Distinguished Chair in Liver Disease.
Atividades
29/08/2024
Externo
20:30 às 22:30 - Atividade Patrocinada - AstraZeneca - Desafios no tratamento atual do Carcinoma Hepatobiliar avançado.
Palestrante
31/08/2024
Plenária
10:30 às 11:15 - Simpósio Satélite ASTRAZENECA - Navigating Complexity in Advanced HCC Management
10:30 às 10:50 - The impact of anti-PD1 and anti CTLA4 in advance HCC, oncologist point of view
Palestrante
31/08/2024
Plenária
10:30 às 11:15 - Simpósio Satélite ASTRAZENECA - Navigating Complexity in Advanced HCC Management
11:00 às 11:15 - Discussion
Debatedor
31/08/2024
Plenária
13:00 às 13:30 - Sessão especial de encerramento - Session B: Hepatobiliary cancers
13:10 às 13:20 - BCLC B HCC: local therapy alone
Palestrante